Squarepoint’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
+100,226
| New | +$232K | ﹤0.01% | 2289 |
|
|
2025
Q1 | – | Sell |
-211,842
| Closed | -$366K | – | 3221 |
|
|
2024
Q4 | $366K | Buy |
211,842
+108,719
| +105% | +$188K | ﹤0.01% | 2100 |
|
|
2024
Q3 | $207K | Buy |
103,123
+22,868
| +28% | +$46K | ﹤0.01% | 2162 |
|
|
2024
Q2 | $180K | Sell |
80,255
-133,691
| -62% | -$299K | ﹤0.01% | 2169 |
|
|
2024
Q1 | $614K | Buy |
213,946
+150,469
| +237% | +$432K | ﹤0.01% | 1571 |
|
|
2023
Q4 | $112K | Buy |
63,477
+34,909
| +122% | +$61.8K | ﹤0.01% | 2256 |
|
|
2023
Q3 | $90.3K | Sell |
28,568
-52,066
| -65% | -$165K | ﹤0.01% | 2268 |
|
|
2023
Q2 | $53.3K | Buy |
+80,634
| New | +$53.3K | ﹤0.01% | 2284 |
|
|
2022
Q1 | – | Sell |
-29,210
| Closed | -$340K | – | 2835 |
|
|
2021
Q4 | $340K | Buy |
+29,210
| New | +$340K | ﹤0.01% | 1803 |
|